E. S. Barton, Junction adhesion molecule is a receptor for reovirus, Cell, vol.104, pp.441-451, 2001.

E. A. Severson and C. A. Parkos, Structural determinants of Junctional Adhesion Molecule A (JAM-A) function and mechanisms of intracellular signaling, Curr Opin Cell Biol, vol.21, pp.701-707, 2009.

J. Gong and M. M. Mita, Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells, Front Oncol, vol.4, 2014.

R. Scientific,

K. L. Norman, K. Hirasawa, A. D. Yang, M. A. Shields, and P. W. Lee, Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection, Proc Natl Acad Sci, vol.101, pp.11099-11104, 2004.

A. and T. , Proteolytic disassembly is a critical determinant for reovirus oncolysis, Mol Ther, vol.15, pp.1512-1521, 2007.

M. R. Duncan, S. M. Stanish, and D. C. Cox, Differential sensitivity of normal and transformed human cells to reovirus infection, J Virol, vol.28, pp.444-449, 1978.

N. Smakman, D. J. Van-den-wollenberg, I. H. Borel-rinkes, R. C. Hoeben, and O. Kranenburg, Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D, J Virol, vol.79, pp.14981-14985, 2005.

J. E. Strong, M. C. Coffey, D. Tang, P. Sabinin, and P. W. Lee, The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus, EMBO J, vol.17, pp.3351-3362, 1998.

W. J. Van-houdt, Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles, Cancer Gene Ther, vol.15, pp.284-292, 2008.

H. Fukuhara, Y. Ino, and T. Todo, Oncolytic virus therapy: A new era of cancer treatment at dawn, Cancer Sci, vol.107, pp.1373-1379, 2016.

J. Gong, E. Sachdev, A. C. Mita, and M. Mita, Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity, World J Methodol, vol.6, pp.25-42, 2016.

X. Zhao, C. Chester, N. Rajasekaran, Z. He, and H. E. Kohrt, Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus, Mol Cancer Ther, vol.15, pp.767-773, 2016.

M. S. Ferguson, N. R. Lemoine, and Y. Wang, Systemic delivery of oncolytic viruses: hopes and hurdles, Adv Virol, vol.805629, 2012.

A. Marchini, E. M. Scott, and J. Rommelaere, Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade, Viruses, vol.8, 2016.

C. Fountzilas, S. Patel, and D. Mahalingam, Review: Oncolytic Virotherapy, updates and future directions, Oncotarget, 2017.

I. J. Dautzenberg, Mammalian orthoreovirus T3D infects U-118 MG cell spheroids independent of junction adhesion molecule-A, Gene Ther, vol.21, pp.609-617, 2014.

W. L. Schulz, A. K. Haj, and L. A. Schiff, Reovirus uses multiple endocytic pathways for cell entry, J Virol, vol.86, pp.12665-12675, 2012.

M. M. Van-oers, G. P. Pijlman, and J. M. Vlak, Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology, J Gen Virol, vol.96, pp.6-23, 2015.

W. X. Ang, Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy, 2016.

S. Asgari and K. N. Johnson, Insect Virology, 2010.

O. Granio, Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus, J Virol, vol.83, pp.6048-6066, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01980932

S. L. Swift, Evaluating baculovirus as a vector for human prostate cancer gene therapy, PLoS One, vol.8, 2013.

D. W. Scott, N-glycosylation controls the function of junctional adhesion molecule-A, Mol Biol Cell, vol.26, pp.3205-3214, 2015.

X. Shi and D. L. Jarvis, Protein N-glycosylation in the baculovirus-insect cell system, Curr Drug Targets, vol.8, pp.1116-1125, 2007.

D. J. Van-den-wollenberg, A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting, Gene Ther, vol.15, pp.1567-1578, 2008.

H. H. Wong, N. R. Lemoine, and Y. Wang, Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles, Viruses, vol.2, pp.78-106, 2010.

N. Mcgranahan, Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade, Science, vol.351, pp.1463-1469, 2016.

T. Stehle and T. S. Dermody, Structural similarities in the cellular receptors used by adenovirus and reovirus, Viral Immunol, vol.17, pp.129-143, 2004.

K. M. Guglielmi, E. Kirchner, G. H. Holm, T. Stehle, and T. S. Dermody, Reovirus binding determinants in junctional adhesion molecule-A, J Biol Chem, vol.282, pp.17930-17940, 2007.

E. Davison, I. Kirby, T. Elliott, and G. Santis, The human HLA-A*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber, J Virol, vol.73, pp.4513-4517, 1999.

G. Santis, Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR, J Gen Virol, vol.80, pp.1519-1527, 1999.

J. D. Chappell, A. E. Prota, T. S. Dermody, and T. Stehle, Crystal structure of reovirus attachment protein sigma1 reveals evolutionary relationship to adenovirus fiber, EMBO J, vol.21, pp.1-11, 2002.

T. Stehle and T. S. Dermody, Structural evidence for common functions and ancestry of the reovirus and adenovirus attachment proteins, Rev Med Virol, vol.13, pp.123-132, 2003.

C. Kataoka, Baculovirus GP64-mediated entry into mammalian cells, J Virol, vol.86, pp.2610-2620, 2012.

C. Wu and S. Wang, A pH-sensitive heparin-binding sequence from Baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cells, J Virol, vol.86, pp.484-491, 2012.

G. Long, X. Pan, R. Kormelink, and J. M. Vlak, Functional entry of baculovirus into insect and mammalian cells is dependent on clathrin-mediated endocytosis, J Virol, vol.80, pp.8830-8833, 2006.

P. Danthi, G. H. Holm, T. Stehle, and T. S. Dermody, Reovirus receptors, cell entry, and proapoptotic signaling, Adv Exp Med Biol, vol.790, pp.42-71, 2013.

O. Meier, Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake, J Cell Biol, vol.158, pp.1119-1131, 2002.

B. Amstutz, Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3, EMBO J, vol.27, pp.956-969, 2008.

J. P. Lim and P. A. Gleeson, Macropinocytosis: an endocytic pathway for internalising large gulps, Immunol Cell Biol, vol.89, pp.836-843, 2011.

M. S. Maginnis, Beta1 integrin mediates internalization of mammalian reovirus, J Virol, vol.80, pp.2760-2770, 2006.

J. C. Means and A. L. Passarelli, Viral fibroblast growth factor, matrix metalloproteases, and caspases are associated with enhancing systemic infection by baculoviruses, Proc Natl Acad Sci, vol.107, pp.9825-9830, 2010.

J. Mu, Live imaging of baculovirus infection of midgut epithelium cells: a functional assay of per os infectivity factors, J Gen Virol, vol.95, pp.2531-2539, 2014.

G. F. Rohrmann, Baculovirus Molecular Biology, 2013.

R. Scientific, M. Egeblad, M. G. Rasch, and V. M. Weaver, Dynamic interplay between the collagen scaffold and tumor evolution, Curr Opin Cell Biol, vol.22, pp.697-706, 2010.

P. Lu, V. M. Weaver, and Z. Werb, The extracellular matrix: a dynamic niche in cancer progression, J Cell Biol, vol.196, pp.395-406, 2012.

C. J. Lehiy, O. Martinez, and A. L. Passarelli, Virion-associated viral fibroblast growth factor stimulates cell motility, Virology, vol.395, pp.152-160, 2009.

A. L. Passarelli, Barriers to success: how baculoviruses establish efficient sestemic infections, Virology, vol.15, pp.383-392, 2011.

S. S. Hong, PUMA gene delivery to synoviocytes reduces inflammation and degeneration of arthritic joints, Nat Commun, vol.8, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02191892

K. E. Makkonen, K. Airenne, and S. Yla-herttulala, Baculovirus-mediated gene delivery and RNAi applications, Viruses, vol.7, pp.2099-2125, 2015.

H. P. Lesch, Requirements for baculoviruses for clinical gene therapy applications, J Invertebr Pathol, vol.107, pp.106-112, 2011.

T. W. Kwang, X. Zeng, and S. Wang, Manufacturing of AcMNPV baculovirus vectors to enable gene therapy trials, Mol Ther Methods Clin Dev, vol.3, 2016.

F. J. Fallaux, Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors, Hum Gene Ther, vol.7, pp.215-222, 1996.